Adrafinil

Adrafinil Research Standard

Adrafinil (2-(diphenylmethylsulfinyl)-N-hydroxyacetamide) is a synthetic, wakefulness-promoting agent characterized primarily as a prodrug to modafinil. In research environments, it serves as a specialized investigative tool for studying the pharmacokinetics of prodrug metabolism and the resultant neuropharmacological effects of its active metabolite. Unlike direct-acting stimulants, adrafinil requires hepatic metabolism to be converted into modafinil, which subsequently modulates central nervous system activity. It is widely utilized in neuroscience research to investigate vigilance, attention, and the neurochemical pathways underlying wakefulness.

Technical Specifications

Mechanism of Action & Research Context

Adrafinil’s research utility is defined by its role as a precursor to the active moiety, modafinil.

• Prodrug Metabolism: Following administration, adrafinil undergoes extensive hepatic metabolism, where it is converted into modafinil, the primary active pharmacological agent. This conversion process is the subject of pharmacokinetic and pharmacodynamic research, as it alters the onset and duration of the resultant physiological effects.

• Pharmacological Activity (via Modafinil): Once converted, the active metabolite interacts with multiple neurotransmitter systems. Research indicates it acts as an atypical dopamine reuptake inhibitor (DRI) at the dopamine transporter (DAT). It also influences the release and transmission of histamine, orexin, glutamate, and GABA, contributing to its wakefulness-promoting profile.

• Receptor Modulation: While historical literature sometimes categorized it as an alpha-1 adrenergic agonist, contemporary research suggests this effect is weak or negligible, pointing toward a more complex modulation of the arousal system rather than direct receptor agonism.

Research Applications

Adrafinil is a specialized reagent essential for comparative pharmacological and pharmacokinetic research.

Primary fields of in vitro and laboratory investigation include:

• Pharmacokinetic Profiling: Analyzing the metabolic clearance and conversion rates of prodrugs into active metabolites in in vivo or microsomal models.

• Vigilance & Wakefulness Models: Investigating the neural mechanisms of alertness and focus in laboratory models of fatigue or sleep-wake cycle disruption.

• Comparative Pharmacodynamics: Benchmarking the efficacy and behavioral effects of adrafinil against direct-acting modafinil to determine the impact of the metabolic conversion process on physiological outcomes.

• Cognitive Research: Studying the compound’s impact on executive function, memory, and psychomotor speed in preclinical models.

Storage & Handling Guidelines

To maintain the chemical stability and experimental reliability of the compound:

• Storage Environment: Store in a cool, dry place. Maintain at -20°C for long-term stability.

• Environmental Control: Protect strictly from light, moisture, and high temperatures, which may degrade the amide and sulfinyl functional groups.

• Handling: Utilize standard laboratory safety practices. Allow the container to equilibrate to room temperature before opening to minimize condensation.

• Aseptic Technique: Ensure the use of sterile laboratory tools to prevent cross-contamination during preparation of solutions for in vitro experiments.

Research Use Disclaimer

Research Use Only Disclaimer: This product is developed and distributed strictly as a Research Use Only (RUO) laboratory reference chemical intended exclusively for non-clinical analytical and scientific investigation. It is not an FDA-approved drug, medical treatment, dietary supplement, or food ingredient, and is strictly prohibited for human or animal consumption. Kimera Chems supplies this high-purity research material solely to qualified institutions and professional investigators for authorized laboratory research.